A Study on the Efficacy of Lumbar Plexus Block in Total Hip Arthroplasty
Not Applicable
- Conditions
- Patients for total hip arthroplasty
- Registration Number
- JPRN-UMIN000043129
- Lead Sponsor
- Itabashi Chuo Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
ASA-PS 3 or higher, not a single operation (e.g. bilateral THA), unobserved withdrawal of antiplatelet/anticoagulant medication, patients with hepatic or renal dysfunction, patients with dementia, patients with allergy to local anesthetics, preoperative opioid use
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain at rest and during movement will be assessed by NRS and compared at 30 minutes, 2 hours, 5 hours, 11 hours, the morning of the first postoperative day, and the morning of the second postoperative day after returning to the ward.
- Secondary Outcome Measures
Name Time Method Presence or absence of motor paralysis and PONV at 30 minutes, 2 hours, 5 hours, 11 hours after returning to the ward, on the morning of the first postoperative day, and on the morning of the second postoperative day, number of times of antiemetic use,number of times rescue was used and time to first use, and patient satisfaction with pain